As the world prepares to celebrate World Malaria Day this Saturday, Kenya stands at a critical turning point in its decades-long struggle against the tropics’ deadliest disease. While the Ministry of Health reports a 32% reduction in the mortality rate over the last ten years and a steady decline in prevalence, the dual challenges of biological resistance and funding shortages now threaten these hard-won gains.
In a press briefing held in Nairobi, Mary Muriuki, the Principal Secretary for Public Health and Professional Standards, stated that Kenya’s strategic interventions have successfully reduced malaria prevalence from 8% to 6% in recent years. Between 2023 and 2025, the incidence rate dropped from 104 to 72 per 1,000 people. However, officials cautioned that this success must be viewed with care, as approximately 75% of the Kenyan population—over 40 million people—remains at risk for the disease.
The World Health Organization (WHO) has issued a stern warning regarding the changing nature of the disease. Neema Rusibamayila Kimambo, the WHO Acting Representative in Kenya, explained that mosquitoes are increasingly developing resistance to the insecticides traditionally used for spraying. This “biological defiance” is particularly evident in high-burden areas like the Lake Victoria Basin and coastal regions, where standard insecticide-treated bed nets are losing their historical effectiveness. Kimambo noted that both this resistance and persistent funding gaps have weakened the fight against malaria. Furthermore, health authorities are monitoring early signs of resistance to malaria medications as well.
To counter these threats, Kenya is shifting aggressively toward modern technologies, emerging as a regional leader in implementing new WHO recommendations. Key interventions include the introduction of dual-active ingredient bed nets, which utilize two different chemicals to kill mosquitoes that have adapted to older insecticides.
Additionally, the rollout of the RTS,S and R21 malaria vaccines has provided a new layer of protection for children under the age of five, who are most vulnerable to the disease. Over 107,000 trained Community Health Promoters are also playing a lead role by providing door-to-door services for early diagnosis and ensuring treatment compliance.
Even though the number of cases dropped to 4.2 million in 2024, the strain on Kenya’s economy remains heavy. Malaria still accounts for 18% of all outpatient visits in public health facilities. For many families, a single bout of malaria can mean the difference between economic stability and poverty.
Because the disease disproportionately affects pregnant women and children, it exacerbates inequality and marginalization in rural areas. In line with its goal to become a “malaria-free nation” by 2030, the Ministry of Health has called for “predictable investment” from the private sector and international donors.
